Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
As of close of business last night, Immix Biopharma Inc’s stock clocked out at $2.7, up 3.05% from its previous closing price of $2.62. In other words, the price has increased by $3.05 from its previous closing price. On the day, 0.69 million shares were traded. IMMX stock price reached its highest trading level at $2.83 during the session, while it also had its lowest trading level at $2.61.
Ratios:
To gain a deeper understanding of IMMX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.23 and its Current Ratio is at 1.23. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.21.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 17 ’25 when Rachman Ilya M bought 2,500 shares for $2.02 per share. The transaction valued at 5,050 led to the insider holds 1,140,937 shares of the business.
Morris Gabriel S bought 2,600 shares of IMMX for $5,122 on Sep 16 ’25. The CFO now owns 290,659 shares after completing the transaction at $1.97 per share. On Jun 18 ’25, another insider, Rachman Ilya M, who serves as the CEO and Chairman of the company, bought 2,178 shares for $2.29 each. As a result, the insider paid 4,999 and bolstered with 1,138,437 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IMMX now has a Market Capitalization of 89195896 and an Enterprise Value of 67256960.
Stock Price History:
The Beta on a monthly basis for IMMX is 0.20, which has changed by 0.5697675 over the last 52 weeks, in comparison to a change of 0.13033986 over the same period for the S&P500. Over the past 52 weeks, IMMX has reached a high of $3.20, while it has fallen to a 52-week low of $1.34. The 50-Day Moving Average of the stock is 20.85%, while the 200-Day Moving Average is calculated to be 27.02%.
Shares Statistics:
It appears that IMMX traded 287.49K shares on average per day over the past three months and 728080 shares per day over the past ten days. A total of 28.41M shares are outstanding, with a floating share count of 16.20M. Insiders hold about 43.82% of the company’s shares, while institutions hold 8.28% stake in the company. Shares short for IMMX as of 1759190400 were 521769 with a Short Ratio of 1.81, compared to 1756425600 on 369043. Therefore, it implies a Short% of Shares Outstanding of 521769 and a Short% of Float of 2.4500001.
Earnings Estimates
. The current rating of Immix Biopharma Inc (IMMX) reflects the combined expertise of 1.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is -$0.17, with high estimates of -$0.17 and low estimates of -$0.17.
Analysts are recommending an EPS of between -$0.62 and -$0.73 for the fiscal current year, implying an average EPS of -$0.68. EPS for the following year is -$0.75, with 2.0 analysts recommending between -$0.69 and -$0.82.
